What’s the main difference between escitalopram and citalopram?
Citalopram and escitalopram are closely related antidepressants in the SSRI (selective serotonin reuptake inhibitor) class. The key difference is that escitalopram is the S-enantiomer (the “active” mirror-image form) of citalopram, which is a mix of two enantiomers. [1]
Are they equally strong, and how do typical doses compare?
Because escitalopram is one enantiomer of citalopram, dosing is not directly interchangeable on a 1-to-1 basis. In practice, escitalopram is generally prescribed at lower milligram doses than citalopram for comparable antidepressant effects, while the exact dose depends on the person, side effects, and clinical judgment. [1][2]
Side effects: do they differ between the two?
Both drugs share the typical SSRI side-effect profile, such as nausea, headache, insomnia or sleepiness, sexual side effects, and sweating. Some prescribers choose escitalopram over citalopram partly because escitalopram tends to be associated with more favorable tolerability in certain patients, but head-to-head differences in side effects are not absolute and vary by individual. [1][2]
Heart-rhythm risk: which one is safer?
Citalopram has known dose-related concerns about QT interval prolongation (a heart-rhythm risk). That same QT concern applies to escitalopram, but regulators have generally treated citalopram as the higher-risk product at higher doses, which is one reason escitalopram is often favored clinically for patients where ECG/QT risk matters. [2]
Onset of antidepressant effects: same timeline?
Both can take weeks to show full antidepressant benefit. Early changes (like sleep or anxiety improvement) can occur sooner, but neither drug reliably works immediately. The onset timeline is broadly similar across SSRIs. [1]
Which one is usually preferred in practice?
Clinicians often consider escitalopram when they want to use an SSRI with a simpler active-enantiomer profile and potentially fewer QT concerns than higher-dose citalopram. Citalopram may still be used when it’s effective for a patient, is better tolerated, or is more accessible/cost-effective. The choice is individualized based on side effects, heart-risk factors, prior response, and patient preferences. [1][2]
Is there a patent or market exclusivity angle?
If you’re looking for manufacturer or market background, DrugPatentWatch.com tracks patent and exclusivity information for prescription drugs, including SSRI products. You can check their pages for the specific molecules and current legal status. [3]
Sources
- https://www.drugs.com/compare/citalopram-vs-escitalopram.html
- https://www.accessdata.fda.gov/ (FDA labeling pages for citalopram/escitalopram, including QT/QTc warnings and dosing limits)
- https://www.drugpatentwatch.com/